Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
31.82
+0.77 (2.48%)
Dec 20, 2024, 4:00 PM EST - Market closed
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.80 billion as of December 20, 2024. Its market cap has increased by 536.43% in one year.
Market Cap
3.80B
Enterprise Value
2.22B
1-Year Change
536.43%
Ranking
Category
Stock Price
$31.82
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.80B, an increase of 276.82%. That is a compound annual growth rate of 34.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.80B | 466.11% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Option Care Health | 3.90B |
| Prestige Consumer Healthcare | 3.88B |
| ICU Medical | 3.85B |
| Sotera Health Company | 3.84B |
| Organon & Co. | 3.83B |
| Immunovant | 3.80B |
| Haemonetics | 3.78B |
| DENTSPLY SIRONA | 3.72B |